How Long Does Mounjaro Stay in Your System?

Tirzepatide has a half-life of roughly five days, so a single dose takes approximately five weeks to leave the body entirely.
Appetite suppression and gastric-emptying effects can persist for days after each weekly injection, which is why missed doses still carry a pharmacological tail.
Because tirzepatide is cleared slowly, restarting after a gap of more than four weeks may require returning to a lower dose — your prescriber decides this.
The long half-life also has practical implications for contraception and surgery planning; NHS guidance sets specific windows for each.

Tirzepatide, the active ingredient in Mounjaro, stays in your system for roughly five weeks after your last injection. It has a half-life of approximately five days, meaning the concentration halves every five days until it clears completely. That long residence time is why once-weekly dosing works — and why effects on appetite and blood sugar persist well beyond each injection day. Because Mounjaro is a prescription-only medicine, any decisions about timing, pausing or stopping should go through your prescriber rather than be based on estimates alone.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the pharmacology means for you in practice

How long does tirzepatide actually take to leave the body?

Tirzepatide's half-life sits at around five days. Work through the maths and you reach roughly five to six half-lives before a drug is considered effectively cleared, putting the full elimination window at approximately 25–30 days, or about five weeks, after your final injection. That figure is consistent across the clinical programme; the NHS tirzepatide medicines page confirms the once-weekly schedule is designed around this pharmacokinetic profile.

In practical terms, the drug doesn't switch off on injection day. For the first day or two after each weekly dose the concentration is rising; it then gently falls until the next pen. Miss a week and you still have meaningful levels aboard. Miss a month and you're starting closer to zero. That gradient matters for understanding side effects, contraception timing, and what happens when treatment pauses.

It's worth noting that "out of your system" and "no longer having any effect" aren't the same thing. At sub-therapeutic concentrations tirzepatide isn't doing much useful work, but trace amounts persist beyond the point where clinical benefit is detectable. For everyday purposes, the five-week elimination window is the number your prescriber will work with. If you want to explore how this compares across formulations, our page on how long tirzepatide stays in your system covers the pharmacology in more detail.

Does the half-life explain why appetite changes linger between doses?

Yes, and this is a question our prescribers hear most weeks, often from people who notice that their hunger stays lower than expected even when they're a few days past injection day. The effect is a direct consequence of the half-life. Tirzepatide activates both GIP and GLP-1 receptors, slowing gastric emptying and reducing appetite signals to the brain. At day five post-injection roughly half the peak concentration remains, so those receptors are still meaningfully engaged. Appetite suppression doesn't simply fall off a cliff on Wednesday if you injected on Saturday.

This same sustained action is one reason the dose-escalation schedule is measured in four-week steps rather than weekly ones. Your body needs time to settle at each concentration level before the prescriber considers moving up. Understanding how long Mounjaro stays active in your system also helps explain why side effects like nausea tend to cluster in the day or two after injection rather than persisting all week, the peak concentration is highest immediately after dosing. If you've been wondering how quickly the medicine begins working from the first pen, the details are covered on how long Mounjaro takes to work.

One practical upshot: if nausea is pronounced in the 24 hours after each pen, that timing is pharmacologically predictable and worth discussing with your prescriber before assuming the treatment isn't right for you.

What does the long elimination window mean for pausing, restarting and surgery?

Several real-life situations hinge directly on how long Mounjaro stays in your system. The most common ones involve planned breaks, surgical procedures and contraception.

For surgery: NHS England advises telling your surgical team and anaesthetist that you are on tirzepatide before any procedure. The slowed gastric emptying that persists across the elimination window raises aspiration risk under general anaesthetic. Timing any pause before an operation is a conversation for your prescriber and surgical team, not a self-managed decision. You can read the current NHS England weight management injections guidance for the formal position.

For contraception: women taking oral contraceptives should add a barrier method for the first four weeks of tirzepatide treatment and for four weeks after each dose increase, because tirzepatide's effect on gastric emptying can reduce pill absorption. That four-week window maps directly onto the drug's half-life logic. More on the contraception interaction is on our Mounjaro treatment page.

For restarting after a gap: if more than four weeks pass without a dose, the prescriber will usually reassess whether returning at the previously established dose is appropriate, or whether restarting at a lower level is safer. This is a clinical call, the duration of Mounjaro's effects in your system is one factor among several the prescriber weighs. If treatment has stopped working as expected, what to do when Mounjaro stops working covers the options. And for cost considerations around any treatment gap, the Mounjaro pricing page sets out what's included in a private prescription.

Can you speed up how quickly Mounjaro clears?

Not in any meaningful clinical sense. Tirzepatide is a large peptide molecule eliminated through normal protein degradation pathways rather than liver metabolism or renal clearance in the way small-molecule drugs are. There is no evidence that increased hydration, dietary changes or exercise alter the clearance rate significantly. The five-week window is determined by the molecule's structure, not by lifestyle factors you can adjust.

What that means practically: if you need tirzepatide out of your system by a specific date (for surgery, a planned pregnancy, or another medical reason) work backwards from that date with your prescriber. Stopping the pen five to six weeks before the target date is the clinical rule of thumb, but your prescriber may advise a longer window depending on the dose you're on and the clinical context. Pregnancy and breastfeeding are clear contraindications; the medicine should be stopped well in advance of any attempt to conceive, with the washout period agreed between you and your prescriber. Under-18s are not licensed for treatment. For broader context on the duration Mounjaro remains in the body, our supporting pages cover additional pharmacokinetic detail. If you'd like to speak with a GPhC-registered prescriber about your specific situation, start a free consultation and our clinical team will review your case the same working day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions